REV-ERBβ emerges as a non-redundant brake on TH17-driven inflammation
New research reveals that the circadian nuclear receptor REV-ERBβ acts as a distinct, non-redundant negative regulator of pro-inflammatory TH17 cell ...
New research reveals that the circadian nuclear receptor REV-ERBβ acts as a distinct, non-redundant negative regulator of pro-inflammatory TH17 cell ...
A new review maps how human immunity develops from a deliberately tolerogenic newborn state through adult peak performance to the ...
MSK scientists identified the long-unknown enzyme behind the inflammatory signal 5-oxoETE and discovered that the pathway also protects healthy cells ...
A new review in the Journal of Molecular Medicine maps how heterogeneous follicular helper T cell subsets are regulated by ...
In a groundbreaking development within pediatric gastroenterology, researchers have unveiled compelling evidence spotlighting the beneficial effects of the probiotic yeast ...
The rapidly evolving field of cell therapies continues to push the boundaries of medicine, seeking to exploit the intrinsic capabilities ...
In a groundbreaking study published in the latest issue of Cell Death Discovery, a team of researchers led by Liu, ...
In the rapidly evolving landscape of immunology, dendritic cells (DCs) have long been recognized as pivotal players bridging the innate ...
In groundbreaking research, scientists at Johns Hopkins Medicine have unveiled a fascinating new role for the protein QRICH1, highlighting its ...
In a groundbreaking discovery that promises to reshape our understanding of autoimmune diseases, researchers from Washington University School of Medicine ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine